ArbiLayer
VITA-FAST logo

Molecules of Korolchuk IP-NFT

VITA-FAST Rank #3501
$0.6286▲ 2.71%24h
Low $0.6006High $0.6577

Price chart

Loading price history…
Market cap$628.6KRank #3501
Fully diluted value$628.6K
Volume (24h)$451.37Vol / Mcap 0.07%
Circulating supply1.00M100.0% of max
Total supply1.00M
Max supply1.00M
All-time high$31.21Nov 19, 2024
All-time low$0.5072Aug 6, 2026

What is Molecules of Korolchuk IP-NFT?

Overview

VITA-FAST tokens are issued by VitaDAO, a decentralized autonomous organization, to fund and democratize longevity research. The project screens bioactive and commercial molecules to identify potential autophagy activators in Npc1-deficient cells, which may lead to treatments for Niemann-Pick Type C disease. Token holders participate in governance decisions regarding the underlying intellectual property and research direction.

How it works

The token operates on Ethereum as an ERC-20 standard contract. It grants fractional ownership of an IP-NFT linked to research conducted at the Korolchuk Lab, enabling token holders to collectively govern scientific research decisions through the VitaDAO framework.

Token and supply

VITA-FAST has a fixed maximum supply of 1 million tokens. The token provides governance rights over the intellectual property associated with the longevity research project, allowing holders to participate in decisions affecting the research program and its outputs.

Where to trade VITA-FAST

Exchanges that list this asset

All markets
#ExchangePairsVolume (24h)
Loading exchanges that list this asset…
Live spot quotes from connected exchanges
VenueBidAskMidStatus
Open to load live quotes.

VITA-FAST funding rates

Live perpetual funding on every connected exchange. Positive = longs pay shorts.

Full view

Contracts & chains

Exact contract or mint per network — the identity layer used for DEX routing.

Resolving token registry…

On-chain routes

Networks with a connected DEX routing adapter.

Loading DEX coverage…

Molecules of Korolchuk IP-NFT news

All news
Loading related headlines…